期刊文献+

临床药师在肿瘤科开展药学服务的几点体会 被引量:3

Experiences on the effect of clinical pharmaceutical care applied by clinical pharmacists in oncology
暂未订购
导出
摘要 目的探讨临床药师在肿瘤科开展药学服务的作用。方法临床药师通过主动与肿瘤科医生、护理人员沟通和交流,从药物的滴注速度、联合用药的给药顺序及对不良反应的处理等多个方面共同探讨肿瘤科病人的用药问题。结果在肿瘤科开展药学服务,可保证医嘱的正确施行及患者的用药安全、有效。结论临床药师通过在肿瘤科进行相应的药学服务,可促进肿瘤科药物的合理、有效的应用。 Objective To study the effect of clinical pharmaceutical care applied by clinical pharmacists in oncology. Methods Clinical pharmacists communicated with the doctors, nurses actively and discussed the drug apphcafion related problems in oncology from different aspects, such as infusion rate, administration order, the treatment of side effects and so on. Results The medical advices were able to be implemented correctly and the safety and validity of medication usage were able to be insured through the pharmaceutical care in oncology. Conclusion The clinical pharmaceutical care applied by clinical pharmacists in oncology was able to promote the reasonable and effective application of drugs in oncology.
作者 孙兴芝 李华
出处 《肿瘤药学》 CAS 2011年第5期464-466,共3页 Anti-Tumor Pharmacy
关键词 临床药师 肿瘤科 药学服务 作用 Clinical pharmacists Oncology Pharmaceutical care Effect
  • 相关文献

参考文献2

二级参考文献19

  • 1Brandi G, Pantaleo MA, Galli C, et al. Hypersensitivity reactions related to oxaliplatin (OHP) [J]. Br J Cancer, 2003, 89(3) :477-481.
  • 2Thomas RR, Quinn MG, Schuler B, et al. Hypersensitivity and idiosyncratic reactions to oxaliplatin [J]. Cancer, 2003, 97(9) : 2301-2307.
  • 3Siu SW, Chan RT, Au GK. Hypersensitivity reactions to oxaliplatin: experience in a single institute [J]. Ann Oncol, 2006,17(2) :259-261.
  • 4Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes [J]. Lancet, 1977,1 ( 8009 ) : 466-469.
  • 5Polyzos A, Tsavaris N, Gogas H, et al. Clinical features of hypersensitivity reactions to oxaliplatin: a 10-year experience [J]. Oncology, 2009,76( 1 ) : 36-41.
  • 6Maindrault-Goebel F, Andre T, Tournigand C, et al. Allergictype reactions to oxaliplatin: retrospective analysis of 42 patients [J ]. Eur J Cancer, 2005,41 (15) : 2262-2267.
  • 7Lee MY, Yang MH, Liu JH, et al. Severe anaphylactic reactions in patients receiving oxaliplatin therapy: a rare but potentially fatal complication [J]. Support Care Cancer, 2007, 15(1):89-93.
  • 8Larzilliere I, Brandissou S, Breton P. et al. Anaphylaetic reaction to oxaliplatin: a case report [J].Am J Gastroenterol, 1999,94( 11 ) :3387-3388.
  • 9Finkehnan FD, Rothenberg ME, Brandt EB, et al. Molecular mechanisms of anaphylaxis: lessons from studies with murine models [J].J Allergy Clin hnmunol, 2005,115(3):449-457.
  • 10Strait R, Morrist SC, Finkelman FD. Cytokine enhancement of anaphylaxis [J]. No~artis Found Syrup, 2004. 257 : 80-91.

共引文献65

同被引文献22

  • 1谭永红,曾仁杰,王诗华,段艳冰,梁蓉梅.临床药师应重视肿瘤患者的药疗监护[J].中国药房,2004,15(12):763-764. 被引量:18
  • 2林晓耘,姚刚,周谊,孙德醒,邓红艳.药物增强华法林抗凝作用5例[J].临床心血管病杂志,2006,22(7):441-441. 被引量:9
  • 3舒展,王悦,翟所迪.环磷酰胺致出血性膀胱炎的监测与防治[J].药物不良反应杂志,2006,8(4):269-272. 被引量:20
  • 4Sweetman SC,李大魁,金有豫,等.马丁代尔药物大典[M].北京:化学工业出版社,2008:773-81.
  • 5宋立刚,彭敦仁.从暂停使用苯丙醇胺类制剂,看开展药品不良反应监测工作的重要性[J].继续医学教育,2011,15(1)58-59.
  • 6Kiani A, K6hne CH, Franz T, et al. Pharmacokinetics of gemcitabine in a patient with end-stage renal disease: effective clearance of its main metabolite by standard hemodialysis treatment [ J ]. Cancer Chemother Pharmaco] ,2003,51 ( 3 ) :266-270.
  • 7Kobayashi Y, Nishimura K, Soda T, et al. Cor bina/ion chemo- therapy with gemcitabine and paclitaxel in a hemodialysis patient with metastatic urothelial carcinoma [ J ]. Hinyokika Kiyo, 2010,56 ( 1 ) :29-34.
  • 8Shah SR, Martin R, Dowell JE, et al. Comparison of the 5- fluorouraeil-warfarin and eapeeitabine-warfarin drug interactions [J]. Pharmaeotherapy,2010,30(12) :1259-1265.
  • 9Yamamuro F, Miki A, Kondo G, et al. Individual differences in prothrombin time-international normalized ratio variation following eoadministration of the antieaneer agents S-I and warIi rin: 3 ease ret orts[ J]. Int J Clin Pharmaeot Ther,2011,49( 11 ) :700-704.
  • 10蔡和平,王卓,黄瑾,等.从药品不良事件谈临床药师对肿瘤患者的用药监护[C].//2010北京国际治疗药物监测和临床毒理学术会议论文集,2010:1-8.

引证文献3

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部